What's New
Notice from SANSHO
2025/10/30 Reacquired License for Quasi-drug Manufacturing and Marketing
2025/10/10 Presented joint research with Tokushima Univ. at ERS Congress 2025
- 2025/06/27 【New Product】Launched “NcPA® Cream α” for full-body aging care
- 2025/06/19 To
present joint research with Tokushima Univ. at ERS Congress 2025
(Pulmonary Fibrosis) - 2025/05/29 Received
milestone payment from Orient EuroPharma
- 2025/02/26 Office
relocation notice
- 2025/01/31 Article
on cPA published in Rinsho Kagaku
(Japanese Journal of Clinical Chemistry) - 2024/11/05 SCRIP Interview Conducted at JHVS 2024 Published
- 2024/08/07 Exhibiting
at Japan Healthcare Venture Summit (JHVS) 2024
- 2024/05/22 Joint
research with Tokushima Univ. presented at ATS International Conference
- 2024/05/01 Taiwan Clinical Trial Results of 2cPA Presented at OARSI 2024
- 2024/04/07 Joint
research with Tokushima Univ. presented
at Japan Respiratory Society Meeting - 2024/02/27 NcPA
manufacturing patent registered in China
- 2024/02/21 Joint research with Tokushima Univ. to be presented at JRS & ATS 2024
- 2024/02/21 Clinical
trial results in Taiwan to be presented at OARSI 2024
- 2023/10/02 Joint Research Presented at the Japan Diffuse Lung Disease Meeting
- 2023/11/29 Patent
application filed for 2cPA in glaucoma treatment
- 2022/10/01 Phase
IIa clinical trial of 2cPA started in Taiwan (Osteoarthritis)
- 2022/05/31 Research
lab relocated to Tsukuba Startup Plaza
- 2021/10/04 Phase
I/b clinical trial of 2cPA completed in Taiwan
- 2020/02/10 NcPA Cosmetic Ingredient Approved as a Quasi-Drug Additive
- 2020/01/24 NcPA ingredient launched as a food material
